Serum Sodium Identifies Patients with Cirrhosis at High Risk of Hepatorenal Syndrome

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Zeitschrift für Gastroenterologie - German Journal of Gastroenterology

• Publication date

  2013-05-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-0032-1330676PMID 23696114
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatorenal Syndrome.

  2019cited by this paper
• Cystatin C: a predictor of hepatorenal syndrome in patients with liver cirrhosis

  2011cited by this paper
• Diagnosis, treatment and survival of patients with hepatorenal syndrome: a survey on daily medical practice.

  2011cited by this paper
• Prevention of hepatorenal syndrome in patients with cirrhosis and ascites: a pilot randomized control trial between pentoxifylline and placebo

  2011cited by this paper
• Creatinine-based glomerular filtration rate estimation in patients with liver disease: the new Chronic Kidney Disease Epidemiology Collaboration equation is not better

  2011cited by this paper
• Hepatorenal syndrome

  2011cited by this paper
• Cystatin C is a good predictor of hepatorenal syndrome and survival in patients with cirrhosis who have normal serum creatinine levels.

  2011cited by this paper
• Renal failure in cirrhosis.

  2009cited by this paper
• Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels

  2009cited by this paper
• Hyponatremia in cirrhosis: Results of a patient population survey

  2006cited by this paper
• Predictive models in portal hypertension

  2006cited by this paper
• Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study.

  2004cited by this paper
• Hepatorenal syndrome.

  2003cited by this paper
• Dilutional hyponatremia in patients with cirrhosis and ascites.

  2002cited by this paper
• Hepatorenal syndrome: diagnostic accuracy, clinical features, and outcome in a tertiary care center

  2002cited by this paper
• Internal validation of predictive models: efficiency of some procedures for logistic regression analysis.

  2001cited by this paper
• Pentoxifylline improves shortterm survival in severe acute alcoholic hepatitis: a doubleblind,placebo-controlled trial.

  2001cited by this paper
• Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.

  2000cited by this paper
• A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

  1999cited by this paper
• Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.

  1996cited by this paper
• Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis

  1996cited by this paper
• Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis

  1994cited by this paper
• Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites.

  1993cited by this paper
• Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis

  1988cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper
• Transection of the oesophagus for bleeding oesophageal varices

  1973cited by this paper

• Evaluation of critical factors predicting the development of hepatorenal syndrome in hospitalized cirrhotic patients

  2025cites this paper
• Establishment and evaluation of an early prediction model of hepatorenal syndrome in patients with decompensated hepatitis B cirrhosis

  2023cites this paper
• Clinical Significance and Management of Hyponatremia in Liver Cirrhosis

  2023cites this paper
• Use of Human Albumin Administration for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis: A Systematic Review and Meta-Analysis

  2022cites this paper
• Predictors of Development of Hepatorenal Syndrome in Hospitalized Cirrhotic Patients with Acute Kidney Injury

  2021cites this paper
• Hyponatremia in Decompensated Chronic Liver Disease, A Marker of Poor Prognosis Hyponatremia; A Red Flag in Chronic Liver Disease

  2021cites this paper
• A clinical risk prediction model to identify patients with hepatorenal syndrome at hospital admission

  2019cites this paper
• Liver Specific Serum Micro RNA122 as a Prognostic Marker in Egyptian Patients with Liver Cirrhosis

  2017cites this paper
• Noradrenaline and Albumin for Type 1 Hepatorenal Syndrome: A Prospective Study from Eastern Nepal

  2017cites this paper
• Influence Factors of Serum Sodium and Prediction of Hyponatremia Using Back Propagation Artificial Neural Network Model (BP-ANN) Model in Cirrhosis Patients

  2016cites this paper
• Hepatorenal Syndrome In Patients With Cirrhosis Of Liver According To 2007 International Ascites Club Criteria.

  2016influential citation
• Comparison of five models for end-stage liver disease in predicting the survival rate of patients with advanced hepatocellular carcinoma

  2016cites this paper
• Prognostic value and treatment of hyponatremia in patients with advanced cirrhosis and acute on chronic liver failure

  2015cites this paper
• Prediction of Hepatorenal Syndrome by Model of End Stage Liver Disease Score

  2013cites this paper